Can liver stiffness testing help detect high central venous pressure in heart failure patients
Official title: Performance of Liver Stiffness Measurement (LSM) by FibroScan® for the Diagnosis of Elevated Central Venous Pressure (CVP)
Run by Echosens · NCT07222813 · Data updated 2026-11-12
A non-invasive FibroScan test is being used to see if liver stiffness can indicate elevated central venous pressure in adults with heart failure.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 149 (estimated) |
| Sponsor | Echosens Industry-sponsored |
| Locations | 7 sites (Los Angeles, California and 6 other locations) |
| Status | Recruiting |
| Started | April 23, 2026 |
| Main results expected | December 31, 2027 |
| Study ends | January 15, 2028 |
| Registry record updated | September 23, 2026 |
| Trial ID | NCT07222813 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with suspected or diagnosed heart failure who are scheduled for right-sided heart catheterization.
✕Probably not a fit
Patients without elevated central venous pressure or with factors that interfere with liver elastography may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter, cross-sectional study tests whether liver stiffness measurements by VCTE correlate with elevated central venous pressure in adults with suspected or diagnosed heart failure who are planned for right-sided heart catheterization. The study compares non-invasive liver elastography with invasive catheter data and standard echocardiography to explore a potential alternative for assessing congestion. It is global, prospective, and involves several sites to evaluate the feasibility and accuracy of this approach. The trial is sponsored by Echosens with collaborators and follows safety and consent procedures for adults. Data from this study could inform non-invasive strategies to manage heart failure congestion.
Why it matters
Potential benefit: If successful, patients may gain a non-invasive option to help detect congestion without invasive catheterization.
How similar studies have gone: Non-invasive liver elastography has shown promise in reflecting hemodynamic changes, but this exact application to detect elevated CVP in heart failure is being explored.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Have read, understood, and signed the informed consent form (ICF) 2. Be ≥18 years of age at the time of screening 3. Have suspected or diagnosed acute or chronic HF and be scheduled to undergo right-sided cardiac catheterization Exclusion Criteria: 1. Inability to consent 2. Chronic liver disease (self-reported alcohol use \>14 drinks/week in females and \>21 drinks/week in males), positive hepatitis C virus serology, positive hepatitis B surface antigen, autoimmune hepatitis, hemochromatosis, or cholestatic disease) 3. BMI \>40 kg/m2 4. Fontan-type circulation 5. Ascites 6. Heart transplantation 7. Pregnancy, breastfeeding, or intent to become pregnant during the study 8. Intent to donate/bank or retrieve eggs (ova, oocytes) or donate sperm during the study
Where it's running
-
University of Minnesota
Minneota, Minnesota, United States Recruiting -
Medical University of South Carolina
Charleston, South Carolina, United States Recruiting -
University of Texas Southwestern Medical Center - Clinical Heart and Vascular Center - West Campus Building 3 Location
Dallas, Texas, United States Recruiting -
Centre Hospitalier Universitaire (CHU) de Rennes - Hopital de Pontchaillou
Rennes, Ile Et Vilaine, France Recruiting -
Deutsches Herzzentrum der Charité (DHZC) - Klinik fuer Herz-, Thorax- und Gefaesschirurgie
Berlin, Germany Recruiting -
Uniwersytet Medyczny im. Piastow Slaskich we Wroclawiu, Instytut Chorob Serca
Wroclaw, Basse-Silésie, Poland Recruiting
Show 1 more location
-
Keck Medicine of USC-Norris Healthcare Center - Transplant Clinic
Los Angeles, California, United States Not yet recruiting
Study contacts
- Study coordinator: CAROLE MEILLEROUX, PharmD
- Email: carole.meilleroux@echosens.com
- Phone: +33622649277
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding Exacerbations in Heart Failure: Monitoring with Apple Watch
This study tests whether data from an Apple Watch, combined with clinical information, can help predict worsening heart failure in adults living with the condition.
-
Using urine sodium to guide IV diuretic dosing for hospitalized acute heart failure
This trial will test whether increasing IV diuretic doses to reach higher urine sodium levels helps hospitalized adults with acute decompensated heart failure remove more salt and fluid and have fewer readmissions.
-
Wearable chest patch that monitors heart mechanics for people with heart failure
This project will try a small wearable chest patch that records heart movement (seismocardiography) and ECG to see if it can detect early worsening in adults with NYHA class II–IV heart failure.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS
Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.